(4S,4aR,7S,7aR,12bS,13S)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9,13-triol
Modify Date: 2023-09-20 17:58:03
![(4S,4aR,7S,7aR,12bS,13S)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9,13-triol Structure](https://www.chemsrc.com/caspic/061/131563-73-0.png)
(4S,4aR,7S,7aR,12bS,13S)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9,13-triol structure
|
Common Name | (4S,4aR,7S,7aR,12bS,13S)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9,13-triol | ||
|---|---|---|---|---|
| CAS Number | 131563-73-0 | Molecular Weight | 301.33700 | |
| Density | 1.54g/cm3 | Boiling Point | 537.2ºC at 760mmHg | |
| Molecular Formula | C17H19NO4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 278.7ºC | |
| Symbol |
GHS02, GHS06, GHS08 |
Signal Word | Danger | |
| Name | (4S,4aR,7S,7aR,12bS,13S)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9,13-triol |
|---|---|
| Synonym | More Synonyms |
| Density | 1.54g/cm3 |
|---|---|
| Boiling Point | 537.2ºC at 760mmHg |
| Molecular Formula | C17H19NO4 |
| Molecular Weight | 301.33700 |
| Flash Point | 278.7ºC |
| Exact Mass | 301.13100 |
| PSA | 73.16000 |
| LogP | 0.62690 |
| Vapour Pressure | 2.27E-12mmHg at 25°C |
| Index of Refraction | 1.747 |
| Symbol |
GHS02, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H301 + H311 + H331-H370 |
| Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
| RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
CAS#:1188377-78-7
CAS#:111271-40-0|
Impurities in a morphine sulfate drug product identified as 5-(hydroxymethyl)-2-furfural, 10-hydroxymorphine and 10-oxomorphine.
J. Pharm. Sci. 92(3) , 485-93, (2003) Stability testing of morphine sulfate formulated with nonpareil sugar seeds (consisting of sucrose and starch) and fumaric acid revealed the formation of the three impurities 5-(hydroxymethyl)-2-furfu... |
|
|
Morphine impurity with opioid activity is identified as 10 alpha-hydroxymorphine.
Pharm. Res. 7(11) , 1205-7, (1990)
|
|
|
Separation of morphine and its oxidation products by capillary zone electrophoresis.
J. Pharm. Biomed. Anal. 20(1-2) , 179-83, (1999) Separation of morphine and its oxidation products (10-S-hydroxymorphine, pseudomorphine and morphine N-oxide) by capillary zone electrophoresis in Tris-borate buffer in the presence of cyclodextrins w... |
| 10-Hydroxymorphine |